Table 1.
Study | Year | Country | Patients | n | Parvovirus B19 detection | Incidence of parvovirus B19 infection (%) | Incidence of anemia among parvovirus B19 infection (%) |
---|---|---|---|---|---|---|---|
Bertoni et al.[10] | 1997 | Italy | Deceased kidney transplant patients with severe hypoproliferative anemia | 9 | PCR | Severe anemia - 4/9 (44.4) | NR |
Gallinella et al.[11] | 1999 | Italy | Kidney transplant patients within 6 months after transplant | 59 | PCR | 0/59 (0) | NR |
Zolnourian et al.[12] | 2000 | Ireland | Kidney transplant patients within 4 months after transplant | 110 | PCR | 2/110 (1.8) | 0/2 (0) |
Malyszko et al.[13] | 2002 | Poland | Kidney transplant patients | 47 | IgM, IgG | IgM - 11/47 (23.4) IgG - 31/47 (66) | NR |
Cavallo et al.[14] | 2003 | Italy | Kidney transplant patients | 48 with anemia 21 without anemia | PCR | With anemia - 11/48 (22.9) Without anemia - 1/21 (4.8) | NR |
Ki et al.[15] | 2005 | South Korea | Kidney transplant patients | 167 | PCR | 52/167 (31.1) | Acute rejection - 7/52 (13) Graft failure - 1/52 (2) Pure red cell aplasia - 2/52 (4) |
Eid et al.[16] | 2006 | US | Kidney transplant patients within 1 year after transplant | 9 | PCR | 0/9 (0) | NR |
Egbuna et al.[17] | 2006 | US | Kidney transplant patients with anemia and erythropoietin resistance | 8 | PCR, IgM, IgG | PCR - 3/8 (37.5) IgM - 1/8 (12.5) IgG - 2/8 (25) | NR |
Ardalan et al.[18] | 2008 | Iran | Kidney transplant patients | 100 | PCR, IgM, IgG | PCR - 6/100 (6) IgM - 6/100 (6) | NR |
Park et al.[19] | 2009 | South Korea | Kidney transplant patients | 143 | PCR | Positive B19 PCR - 84/143 (58.7) High titer >106 copies/5 µL - 13/143 (9.1) | Persistent severe anemia Positive B19 PCR - 13/84 (15) High titer - 11/13 (85) Anemia at 6 months Positive B19 PCR - 13/84 (15) High titer - 3/13 (23) Anemia at 12 months Positive B19 PCR - 9/84 (11) High titer - 1/13 (8) |
Čapenko et al.[20] | 2012 | Latvia | Deceased kidney transplant patients | 63 (38 with anemia, 25 without anemia) | PCR and IgM | All - 12/63 (19) With anemia - 12/38 (31.6) Without anemia - 0/25 (0) | Anemia - 12/12 (100) EPO-resistant severe anemia - 7/12 (58) |
Carraturo et al.[21] | 2012 | Italy | Kidney transplant patients | 64 (14 with anemia, 50 without anemia) | PCR | All - 2/64 (3) With anemia - 0/14 (0) Without anemia - 2/50 (4) | 0/2 (0) |
Plentz et al.[5] | 2013 | Germany | Kidney transplant patients within 6 months after transplant | 147 | PCR | 2/147 (1.4) | NR |
Porignaux et al.[22] | 2013 | France | Kidney transplant patients within 1 year after transplant | 60 | PCR | 6/60 (10) | NR |
Khameneh et al.[23] | 2014 | Iran | Kidney transplant patients with anemia | 91 | IgG | 63/91 (69.2) | Anemia - 63/63 (100) Severe anemia - 47/63 (75) |
Pambrun et al.[24] | 2014 | France | Kidney transplant patients undergoing bone marrow aspiration for cytopenia | 72 | PCR | Bone marrow - 11/72 (15.3) Blood - 4/72 (5.5) | NR |
Krishnan et al.[25] | 2015 | USA | Kidney transplant patients | 144 | PCR or IgM | 3/144 (2.1) | 3/3 (100) |
Baek et al.[26] | 2017 | South Korea | Kidney transplant patients | 602 | PCR | 39/602 (6.5) | Severe anemia (Hb <7) - 27/39 (69) |
Xiao et al.[27] | 2013 | China | Living related kidney transplant patients | 144 | PCR | 27/144 (18.8) | PRCA - 2/27 (7.4) |
EPO: Erythropoietin, IgG: Immunoglobulin G, NR: Not reported, IgM: Immunoglobulin M, PCR: Polymerase chain reaction, PRCA: Pure red cell aplasia, Hb: Hemoglobin